Second, degradation of ILEI by the ubiquitin/proteasome system was originally described in a prostate cancer model and we did not observe any effect of MG-132-mediated proteasome inhibition on ILEI expression in the melanoma cell line model (S2 Fig). The gene discussed is FAM3C; the disease is melanoma.